Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 13 studies | 43% ± 20% | |
keratinocyte | 4 studies | 33% ± 13% |
Insufficient scRNA-seq data for expression of TP63 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 81% | 3288.76 | 199 / 245 | 43% | 10.03 | 215 / 502 |
bladder | 43% | 2703.29 | 9 / 21 | 59% | 52.40 | 296 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.16 | 1 / 1 |
esophagus | 38% | 5067.48 | 555 / 1445 | 60% | 201.56 | 110 / 183 |
tonsil | 0% | 0 | 0 / 0 | 98% | 198.42 | 44 / 45 |
muscle | 94% | 3846.84 | 758 / 803 | 0% | 0 | 0 / 0 |
skin | 72% | 15508.60 | 1304 / 1809 | 8% | 2.94 | 37 / 472 |
breast | 45% | 1417.62 | 205 / 459 | 26% | 5.85 | 289 / 1118 |
uterus | 2% | 184.28 | 3 / 170 | 62% | 90.90 | 283 / 459 |
lung | 1% | 19.44 | 7 / 578 | 47% | 108.91 | 544 / 1155 |
lymph node | 0% | 0 | 0 / 0 | 45% | 11.55 | 13 / 29 |
thymus | 0% | 4.05 | 2 / 653 | 20% | 12.57 | 120 / 605 |
pancreas | 0% | 0 | 0 / 328 | 15% | 5.67 | 26 / 178 |
peripheral blood | 8% | 199.37 | 78 / 929 | 0% | 0 | 0 / 0 |
intestine | 0% | 0 | 0 / 966 | 3% | 1.31 | 15 / 527 |
stomach | 1% | 9.24 | 2 / 359 | 1% | 0.12 | 3 / 286 |
brain | 0% | 0.88 | 2 / 2642 | 1% | 0.24 | 8 / 705 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.10 | 3 / 430 |
adipose | 1% | 30.57 | 8 / 1204 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.46 | 4 / 901 |
adrenal gland | 0% | 9.37 | 1 / 258 | 0% | 0 | 0 / 230 |
liver | 0% | 0 | 0 / 226 | 0% | 0.06 | 1 / 406 |
blood vessel | 0% | 9.88 | 2 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0042475 | Biological process | odontogenesis of dentin-containing tooth |
GO_0060197 | Biological process | cloacal septation |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_1904888 | Biological process | cranial skeletal system development |
GO_0048807 | Biological process | female genitalia morphogenesis |
GO_0060529 | Biological process | squamous basal epithelial stem cell differentiation involved in prostate gland acinus development |
GO_0009954 | Biological process | proximal/distal pattern formation |
GO_0007283 | Biological process | spermatogenesis |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0048485 | Biological process | sympathetic nervous system development |
GO_0061436 | Biological process | establishment of skin barrier |
GO_0008340 | Biological process | determination of adult lifespan |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0031069 | Biological process | hair follicle morphogenesis |
GO_0042771 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_0060513 | Biological process | prostatic bud formation |
GO_0007499 | Biological process | ectoderm and mesoderm interaction |
GO_2000648 | Biological process | positive regulation of stem cell proliferation |
GO_0072089 | Biological process | stem cell proliferation |
GO_0010838 | Biological process | positive regulation of keratinocyte proliferation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0035115 | Biological process | embryonic forelimb morphogenesis |
GO_0033147 | Biological process | negative regulation of intracellular estrogen receptor signaling pathway |
GO_0035116 | Biological process | embryonic hindlimb morphogenesis |
GO_0010482 | Biological process | regulation of epidermal cell division |
GO_0051262 | Biological process | protein tetramerization |
GO_0045617 | Biological process | negative regulation of keratinocyte differentiation |
GO_0051402 | Biological process | neuron apoptotic process |
GO_2000271 | Biological process | positive regulation of fibroblast apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0036342 | Biological process | post-anal tail morphogenesis |
GO_2000381 | Biological process | negative regulation of mesoderm development |
GO_0010481 | Biological process | epidermal cell division |
GO_0043589 | Biological process | skin morphogenesis |
GO_0006915 | Biological process | apoptotic process |
GO_0001501 | Biological process | skeletal system development |
GO_1904674 | Biological process | positive regulation of somatic stem cell population maintenance |
GO_0090398 | Biological process | cellular senescence |
GO_0045747 | Biological process | positive regulation of Notch signaling pathway |
GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0043616 | Biological process | keratinocyte proliferation |
GO_0002064 | Biological process | epithelial cell development |
GO_0001736 | Biological process | establishment of planar polarity |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0030859 | Biological process | polarized epithelial cell differentiation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003684 | Molecular function | damaged DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0050699 | Molecular function | WW domain binding |
GO_0097371 | Molecular function | MDM2/MDM4 family protein binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0002039 | Molecular function | p53 binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TP63 |
Protein name | Cellular tumor antigen p53 Tumor protein p63 Tumor protein 63 (p63) (Chronic ulcerative stomatitis protein) (CUSP) (Keratinocyte transcription factor KET) (Transformation-related protein 63) (TP63) (Tumor protein p73-like) (p73L) (p40) (p51) Tumor protein 63 (p63) |
Synonyms | P73L P73H KET hCG_16028 P63 TP73L |
Description | FUNCTION: Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. . FUNCTION: Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. Isoform 2 activates RIPK4 transcription. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. Involved in Notch signaling by probably inducing JAG1 and JAG2. Plays a role in the regulation of epithelial morphogenesis. The ratio of DeltaN-type and TA*-type isoforms may govern the maintenance of epithelial stem cell compartments and regulate the initiation of epithelial stratification from the undifferentiated embryonal ectoderm. Required for limb formation from the apical ectodermal ridge. Activates transcription of the p21 promoter. . FUNCTION: Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. . FUNCTION: Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. . FUNCTION: Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. . FUNCTION: Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. . FUNCTION: Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. . |
Accessions | A0A0S2Z4N6 ENST00000320472.9 [Q9H3D4-7] A0A0S2Z4N5 ENST00000264731.8 [Q9H3D4-1] C9JW72 C9D7D0 ENST00000434928.5 ENST00000449992.5 [Q9H3D4-10] A0A141PNN4 ENST00000354600.10 [Q9H3D4-2] ENST00000456148.1 [Q9H3D4-12] ENST00000437221.5 [Q9H3D4-6] Q9H3D4 ENST00000392461.7 [Q9H3D4-8] ENST00000440651.6 [Q9H3D4-11] ENST00000392460.7 [Q9H3D4-3] ENST00000418709.6 [Q9H3D4-5] A0A141PNN3 C9D7C9 ENST00000392463.6 [Q9H3D4-4] |